Skandinaviska Enskilda Banken (SEB)’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-140,500	Closed	-$2.31M	–	981
2023 Q4	$2.31M	Buy	+140,500	New	+$2.21M	0.01%	555

Skandinaviska Enskilda Banken (SEB)'s ORTX Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 140,500 shares — an estimated $2.31M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $2.31M in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Skandinaviska Enskilda Banken (SEB) reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 140,500 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $2.31M.
Skandinaviska Enskilda Banken (SEB) first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Skandinaviska Enskilda Banken (SEB)'s Orchard Therapeutics plc American Depositary Shares position peaked at $2.31M in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.